Target groups/end users

The main results of the Action will benefit to all partner types: at the time of preparation, 42 active research and academic institutes in the field of biomaterials (material and physical sciences, biological sciences and tissue engineering, medicine institutes); 17 industries: medical device manufacturers and suppliers, biotech companies but also innovative technology providers (rapid manufacturing techniques); 7 clinicians, medical doctors and surgeons. Of course all the partners have been involved in the preparation of the Action. Finally, the millions of patients (in Europe, but largely more in the whole world) that will require bone implants or bone regeneration engineering will benefit of the innovations issued from the network.